Loading market dashboard

Financials in USD. Standardized financial statements.
A compact view of how China Traditional Chinese Medicine Holdings Co. Limited turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $14.36B | $16.51B | $18.12B | $14.30B | $19.05B | $14.81B | $14.32B | $11.26B | $8.34B | $6.53B |
| Revenue Growth? | -13.0% | -8.9% | +26.7% | -24.9% | +28.7% | +3.4% | +27.2% | +35.0% | +27.6% | 0.0% |
| Cost of Revenue? | $7.46B | $8.65B | $8.85B | $7.11B | $7.22B | $5.68B | $5.75B | $5.07B | $3.69B | $2.75B |
| Gross Profit? | $6.91B | $7.86B | $9.27B | $7.20B | $11.83B | $9.13B | $8.58B | $6.19B | $4.65B | $3.79B |
| Gross Margin? | +48.1% | +47.6% | +51.2% | +50.3% | +62.1% | +61.6% | +59.9% | +55.0% | +55.8% | +58.0% |
| Operating Expenses? | $6.61B | $7.52B | $7.85B | $6.13B | $9.12B | $6.65B | $6.14B | $4.22B | $2.93B | $2.42B |
| Operating Income? | $297.75M | $335.59M | $1.43B | $1.06B | $2.75B | $2.49B | $2.46B | $2.16B | $1.79B | $1.44B |
| EBITDA? | $1.40B | $1.53B | $2.56B | $2.16B | $3.59B | $3.16B | $3.05B | $2.66B | $2.19B | $1.71B |
| Income Before Tax | -$358.73M | $163.11M | $1.22B | $840.11M | $2.52B | $2.23B | $2.15B | $1.86B | $1.57B | $1.30B |
| Income Tax Expense | $87.54M | $142.34M | -$171.54M | $119.36M | $396.86M | $369.45M | $381.32M | $289.67M | $255.80M | $217.26M |
| Net Income? | -$333.24M | $54.07M | $1.29B | $764.49M | $1.93B | $1.66B | $1.59B | $1.44B | $1.17B | $966.93M |
| EPS? | $-0.07 | $0.01 | $0.26 | $0.15 | $0.38 | $0.33 | $0.32 | $0.30 | $0.26 | $0.22 |
| Diluted EPS? | $-0.07 | $0.01 | $0.26 | $0.15 | $0.38 | $0.33 | $0.32 | $0.30 | $0.26 | $0.22 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality